Khan Samina 4
4 · REATA PHARMACEUTICALS INC · Filed May 17, 2023
Insider Transaction Report
Form 4
Khan Samina
SVP, Chief Medical Officer
Transactions
- Sale
Class A common stock
2023-05-15$85.32/sh−288$24,572→ 39,843 total - Sale
Class A common stock
2023-05-16$81.37/sh−352$28,642→ 39,491 total
Footnotes (1)
- [F1]The sale reported on this line represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units.